Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | ALB | P02768 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 3/20 | 0.36 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22506807 | 0.95 | LOXL2 (0.58) | LOXL2TTRALBCYP2A6MEN1 | |
| SCHEMBL30335660 | 0.84 | LOXL2 (0.48) | LOXL2 | |
| SCHEMBL319482 | 0.84 | LOXL2 (0.48) | LOXL2 | |
| SCHEMBL7896912 | 0.84 | LOXL2 (0.48) | LOXL2TTRALBCYP2A6NSD2 | |
| SCHEMBL1363861 | 0.84 | LOXL2 (0.48) | LOXL2TTRALBCYP2A6MEN1 | |
| SCHEMBL25054279 | 0.84 | LOXL2 (0.48) | LOXL2NSD2IDO1 | |
| SCHEMBL7403363 | 0.84 | LOXL2 (0.48) | LOXL2TTRALBCYP2A6MEN1 | |
| Hydrochloric Acid SCHEMBL32675272 | 0.83 | LOXL2 (0.47) | LOXL2TTRALBNSD2 | |
| SCHEMBL32675279 | 0.81 | LOXL2 (0.45) | LOXL2TTRALBCYP2A6NSD2 | |
| SCHEMBL169517 | 0.80 | RXRA (0.46) | LOXL2MEN1KMT2ANSD2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110234630-B | Phenylimidazolines having aminomethyl groups Compound or salt thereof and process for producing the same | 三菱瓦斯化学株式会社 | 2023-02-03 | — | — | CN | disclosed |
| EP-3604286-B1 | PHENYL IMIDAZOLINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, OR PHENYL TETRAHYDROPYRIMIDINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND PRODUCTION METHOD OF SAID COMPOUNDS OR SALTS THEREOF | MITSUBISHI GAS CHEMICAL CO (JP) | 2022-01-19 | — | — | EP | disclosed |
| US-11198676-B2 | Phenyl imidazoline compound having aminomethyl group or salt thereof, or phenyl tetrahydropyrimidine compound having aminomethyl group or salt thereof, and production method for such compounds or salts thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-12-14 | — | — | US | disclosed |
| US-20200339516-A1 | PHENYL IMIDAZOLINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, OR PHENYL TETRAHYDROPYRIMIDINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND PRODUCTION METHOD FOR SUCH COMPOUNDS OR SALTS THEREOF | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-10-29 | — | — | US | disclosed |
| EP-3604286-A1 | PHENYL IMIDAZOLINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, OR PHENYL TETRAHYDROPYRIMIDINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND PRODUCTION METHOD OF SAID COMPOUNDS OR SALTS THEREOF | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-3031803-B1 | BENZOGUANAMINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND METHOD FOR MANUFACTURING SAME | MITSUBISHI GAS CHEMICAL CO (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-9458116-B2 | Benzoguanamine compound having aminomethyl group, or salt thereof, and method for manufacturing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20160176827-A1 | BENZOGUANAMINE COMPOUND HAVING AMINOMETHYL GROUP, OR SALT THEREOF, AND METHOD FOR MANUFACTURING THE SAME | MITSUBHIS GAS CHEMICAL COMPANY, INC. (JP) | 2016-06-23 | — | — | US | disclosed |
| EP-3031803-A1 | BENZOGUANAMINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND METHOD FOR MANUFACTURING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2016-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339516-A1 | PHENYL IMIDAZOLINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, OR PHENYL TETRAHYDROPYRIMIDINE COMPOUND HAVING AMINOMETHYL GROUP OR SALT THEREOF, AND PRODUCTION METHOD FOR SUCH COMPOUNDS OR SALTS THEREOF | JAK2, IL4I1, INMT | LOXL2 4761/4885TTR 3994/4885ALB 2329/4885 |
| US-11198676-B2 | Phenyl imidazoline compound having aminomethyl group or salt thereof, or phenyl tetrahydropyrimidine compound having aminomethyl group or salt thereof, and production method for such compounds or salts thereof | JAK2, IL4I1, INMT | LOXL2 4761/4885TTR 3994/4885ALB 2329/4885 |
| US-20160176827-A1 | BENZOGUANAMINE COMPOUND HAVING AMINOMETHYL GROUP, OR SALT THEREOF, AND METHOD FOR MANUFACTURING THE SAME | BCAT2, GNMT, BCAT1 | LOXL2 3127/4885TTR 3569/4885ALB 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.